BridgeBio Pharma
BBIO
#2325
Rank
S$8.36 B
Marketcap
$43.96
Share price
2.04%
Change (1 day)
17.18%
Change (1 year)

BridgeBio Pharma (BBIO) - Cash on Hand

Cash on Hand as of December 2024 : S$0.90 Billion

According to BridgeBio Pharma 's latest financial reports the company has S$0.90 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BridgeBio Pharma - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.92 B61.19%
2023-12-31S$0.57 B-9.22%
2022-12-31S$0.63 B-44.07%
2021-12-31S$1.13 B40.83%
2020-12-31S$0.80 B9.11%
2019-12-31S$0.73 B23.56%
2018-12-31S$0.59 B384.19%
2017-12-31S$0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$21.85 M-97.59%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.57 B-36.58%๐Ÿ‡บ๐Ÿ‡ธ USA